Sean McCann, Victória E Helfer, Stephen J Balevic, Chi D Hornik, Stuart L Goldstein, Julie Autmizguine, Marisa Meyer, Amira Al-Uzri, Sarah G Anderson, Elizabeth H Payne, Sitora Turdalieva, Daniel Gonzalez
Dexmedetomidine is a sedative used in both adults and off-label in children with considerable reported pharmacokinetic (PK) interindividual variability affecting drug exposure across populations. Several published models describe the population PKs of dexmedetomidine in neonates, infants, children, and adolescents, though very few have been externally evaluated. A prospective PK dataset of dexmedetomidine plasma concentrations in children and young adults aged 0.01-19.9 years was collected as part of a multicenter opportunistic PK study...
March 28, 2024: Journal of Clinical Pharmacology